Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUOXETINE | 10MG | CAPSULE | Resolved | 2024-12-11 | 2025-03-14 | 245456 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-09-16 | 2022-09-30 | 169510 |
| APO-FLUOXETINE | 20MG | SOLUTION | Resolved | 2023-04-27 | 2023-05-06 | 190850 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-26 | 2024-03-01 | 220650 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-11-04 | 2023-03-02 | 173815 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-10-27 | 2023-11-06 | 208406 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-11-14 | 2024-12-20 | 243089 |
| APO-FLUTICASONE HFA | 50MCG | AEROSOL, METERED DOSE | Actual shortage | 2026-01-16 | 2026-01-16 | 276268 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-02-23 | 2023-03-02 | 185486 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-07-12 | 2024-08-09 | 232835 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-04-06 | 2023-07-27 | 188940 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-10-20 | 2024-01-19 | 207710 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-02-17 | 179453 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Resolved | 2020-10-14 | 2020-11-02 | 126280 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Resolved | 2021-11-01 | 2021-11-29 | 148587 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154759 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154756 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Resolved | 2021-10-15 | 2021-11-29 | 147292 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-METFORMIN - TAB 500MG | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN - TAB 500MG | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN - TAB 500MG | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN 850 MG TABLETS | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-METFORMIN 850 MG TABLETS | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
| APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
| APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |